Overview

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy and safety of Teicoplanin versus Vancomycin as part of the initial antibiotic regimen in the therapy of patients with fever and neutropenia .
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Anti-Bacterial Agents
Teicoplanin
Vancomycin